Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
about
The History of Mycoplasma pneumoniae PneumoniaChlamydia pneumoniae is genetically diverse in animals and appears to have crossed the host barrier to humans on (at least) two occasionsPlasmacytoid dendritic cells play a role for effective innate immune responses during Chlamydia pneumoniae infection in miceInsight into disulfide bond catalysis in Chlamydia from the structure and function of DsbH, a novel oxidoreductaseThe transcriptional landscape of Chlamydia pneumoniaeChlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and patients with diabetes mellitus, acute coronary syndrome, stroke, and arterial hypertensionProteome analysis of the Chlamydia pneumoniae elementary body.Time-dependent expression and processing of a hypothetical protein of possible importance for regulation of the Chlamydia pneumoniae developmental cycle.Newly characterized species-specific immunogenic Chlamydophila pneumoniae peptide reactive with murine monoclonal and human serum antibodiesEndotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC.Inclusion biogenesis and reactivation of persistent Chlamydia trachomatis requires host cell sphingolipid biosynthesisGenomic approach for analysis of surface proteins in Chlamydia pneumoniaeGene expression profiles of Chlamydophila pneumoniae during the developmental cycle and iron depletion-mediated persistenceRNAi screen in Drosophila cells reveals the involvement of the Tom complex in Chlamydia infection.Chlamydophila pneumoniae derived from inclusions late in the infectious cycle induce aponecrosis in human aortic endothelial cellsMulti locus sequence typing of Chlamydiales: clonal groupings within the obligate intracellular bacteria Chlamydia trachomatisAttachment and entry of Chlamydia have distinct requirements for host protein disulfide isomerase.Trophoblast infection with Chlamydia pneumoniae and adverse pregnancy outcomes associated with placental dysfunction.A novel inhibitor of Chlamydophila pneumoniae protein kinase D (PknD) inhibits phosphorylation of CdsD and suppresses bacterial replication.Interactions between flagellar and type III secretion proteins in Chlamydia pneumoniae.Association of carotid plaque Lp-PLA(2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke.Comparison of koala LPCoLN and human strains of Chlamydia pneumoniae highlights extended genetic diversity in the species.Multi locus sequence typing of Chlamydia reveals an association between Chlamydia psittaci genotypes and host species.Atherosclerosis, inflammation and Chlamydia pneumoniae.Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland.Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo.Ectasia and severe atherosclerosis: relationships with chlamydia pneumoniae, helicobacterpylori, and inflammatory markersImmune response to chlamydial 60-kilodalton heat shock protein in tears from Nepali trachoma patientsChlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells.Sodium ion cycle in bacterial pathogens: evidence from cross-genome comparisonsChlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors required for [correction of factors is required for] major histocompatibility complex antigen expression.Immunity to murine chlamydial genital infection.Persistent Chlamydophila pneumoniae infection in thoracic aortic aneurysm and aortic dissection?Heat shock protein 60 specific T-cell response in chlamydial infections.Association of HLA-DRB3*0202 and serum IgG antibodies to Chlamydia pneumoniae with essential hypertension in a highly homogeneous population from Majorca (Balearic Islands, Spain).Immunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathologyThe seroepidemiology of the chronic infections in patients with myocardial infarction in North of Iran.All subtypes of the Pmp adhesin family are implicated in chlamydial virulence and show species-specific function.Temporal expression of type III secretion genes of Chlamydia pneumoniae.Chlamydia pneumoniae infection in mice induces chronic lung inflammation, iBALT formation, and fibrosis.
P2860
Q26752305-FF60293F-D38B-43EA-8BF7-8D40CC1CACE7Q27314770-B9012255-9BE8-40D7-A717-57F9D8C5BC18Q27340476-64F766A1-6CDF-46A2-BE56-6DA2F5138605Q27649041-C12A3254-0C28-4829-BDD6-C00378538F30Q27825840-E1946C79-F1A4-41C6-AE03-B083BF832480Q28182623-321AA75E-56B4-4AEB-8767-F46D04740E1EQ30669016-6961F39C-4F18-4EB2-A312-B77019D47281Q30682022-6DB9208B-C3EA-4CA0-A3BF-37D310670F8AQ30821899-D045A99B-4C56-4E0B-8253-EB8830DD1FCBQ30883028-6048136C-26A9-4AB8-B078-24B18D5390F5Q30912299-20674D63-E8C1-4A1D-BD68-7BFAF3D003EBQ31032708-BC9BAF11-0117-49B5-BF51-1CC1569EAA34Q33288727-D845EBEB-2214-4BE8-9B31-E16915F8EC59Q33304217-175651BF-5218-4C69-9DA9-5EAD09AEBBAEQ33320332-FE94E151-509A-4AB1-B4D8-1CD4B1350661Q33321686-BAC1AC7E-BABF-4DC8-9FFD-FC326308CC50Q33426342-CC20D4EF-14E8-4B81-9864-5ED8D76935ECQ33431609-DB3680FA-D4D1-4139-AC7B-DD13364A04EBQ33510432-9BA9CF9A-C5C3-4288-9C05-501B220BED4EQ33526048-AAB6B277-D354-486B-9F5E-8116DD2065B6Q33602983-08AA6714-2DCB-45F4-8EB1-A2FEBF951BF8Q33636893-B606C53C-5674-47E6-A556-F77594249444Q33769851-D644104A-D345-48B4-B4FD-826199D21D15Q33772514-806B180C-491D-46B2-8CE6-5E80A4937050Q33788646-9EA2AFAA-1707-47AD-BB62-82BCD7DC53BEQ33927267-391A3C31-E7E8-4533-9165-451598ADF3F1Q33935504-60D6A65E-371A-4CF4-A3C6-7846333BA4B5Q34008628-747BE635-DB10-4336-AE2C-69B1A8698383Q34008875-DC5FAEB2-5608-493E-9615-5F040423ADD1Q34010367-7CAEB794-EBA3-4933-8B1F-125308690FB5Q34116447-FDC086CB-5D13-49A5-BF32-12715C1DDAE6Q34124225-1A51DA5F-DD15-41EE-B9B2-C17661B1F195Q34128118-2E3BB7A3-D44D-4129-B3CD-E390BF559B05Q34299869-3AD5621F-DADA-4F93-97DE-F38507255710Q34420129-57F096BD-3DF0-4D5F-ABBC-3393C53EE4F7Q34685461-6642F1D9-122E-4C56-8C39-42722EBF7A19Q34863840-1A618E8F-E67A-42CB-A33B-ACCE4775E9CEQ34870145-6B00EC88-C42C-48D7-829A-15D8AF78B71BQ34935390-468D7C21-6116-423E-A656-5CC82A476DA0Q35035253-A5E638AE-4186-4228-8B8C-489AF3BC0B13
P2860
Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
@ast
Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
@en
type
label
Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
@ast
Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
@en
prefLabel
Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
@ast
Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
@en
P2860
P356
P1476
Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
@en
P2093
Grayston JT
P2860
P304
P356
10.1086/315596
P407
P478
181 Suppl 3
P577
2000-06-01T00:00:00Z